Advertisement

Autoimmune mechanisms as the basis for human peripartum cardiomyopathy

Abstract

The etiology and mechanisms of pathogenesis of human peripartum cardiomyopathy (PPCM) remain unknown. The incidence and prevalence of this disease is rare in some parts of the world and more common in others. The purpose of this review is to summarize our current knowledge of the factors that have been entertained which may contribute to the pathogenesis of PPCM with special emphasis on more recent data from our laboratory that provide support to the view that this disease is an autoimmune disease with multiple contributing factors and effector mechanisms. This is supported by the fact that sera from PPCM patients contain high titers of autoantibodies against normal human cardiac tissue proteins of 37, 33, and 25 kD that was not present in the sera of patients with idiopathic cardiomyopathy (IDCM), indicating for the first time that PPCM is distinct from IDCM. In addition to the autoantibodies, the PBMC's from PPCM patients demonstrate a heightened level of fetal microchimerism, an abnormal cytokine profile, decreased levels of CD4+ CD25lo regulatory T cells, and a significant reduction in the plasma levels of progesterone, estradiol and relaxin in PPCM patients as compared with other normal pregnant non-PPCM patients. A potential role for reduced plasma levels of selenium in the pathogenesis of select PPCM patients was also noted. These findings for the first time suggest that such abnormalities may in concert lead to the initiation and perpetuation of an autoimmune process, which leads to cardiac failure and disease. Identification of the precise nature of the cardiac tissue autoantigens (currently in progress) will pave the way for the delineation of mechanism of this autoimmune disease. A working model for the pathogenesis of this disease is also described herein.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Pearson, G. D., Veille, J. C., Rahimtoola, S., Hsia, J., Oakley, C. M., Hosenpud, J. D., et al. (2000), JAMA 283, 1183–1188.

  2. 2.

    Lampert, M. B. and Lang, R. M. (1995), Am. Heart J. 130, 860–870.

  3. 3.

    Cunningham, F. G., Pritchard, J. A., Hankins, G. D., Anderson, P. L., Lucas, M. J., and Armstrong, K. F. (1986), Obstet. Gynecol. 67, 157–168.

  4. 4.

    Knobel, B., Melamud, E., and Kishon, Y. (1984), Isr. J. Med. Sci. 20, 1061–1063.

  5. 5.

    Lasinska-Kowara, M., Dudziak, M., and Suchorzewska, J. (2001), Can. J. Anaesth. 48, 773–777.

  6. 6.

    Sakakibara, S., Sekiguchi, M., Konno, S., and Kusumoto, M. (1970), Am. Heart J. 80, 385–395.

  7. 7.

    Felker, G. M. and O'Connor, C. M. (2000), Am. Heart J. 140, 785–791.

  8. 8.

    Fett, J. D., Carraway, R. E., Dowell, D. L., King, M. E., and Pierre, R. A. (2002), Am. J. Obstet. Gyn. 186, 1005–1010.

  9. 9.

    Mosmann, T. R. and Coffman, R. L. (1989), Ann. Rev. Immunol. 7, 145–173.

  10. 10.

    Coffman, R. L., Seymour, B. W., Lebman, D. A., Hiraki, D. D., Christiansen, J. A., Shrader, B., et al. (1988), Immunol. Rev. 102, 5–58.

  11. 11.

    Cerwenka, A. and Swain, S. L. (1999), Microbes Infect. 1, 1291–1296.

  12. 12.

    Shevach, E. M. (2000), Annu. Rev. Immunol. 18, 423–449.

  13. 13.

    Shevach, E. M. (2001), J. Exp. Med. 193, F41-F46.

  14. 14.

    Han, X., Lundberg, P., Tanamachi, B., Openshaw, H., Longmate, J., and Cantin, E. (2001), J. Virol. 75, 3048–3052.

  15. 15.

    Bruland, T., Dai, H. Y., Lavik, L. A., Kristiansen, L. I., and Dalen, A. (2001), J. Gen. Virol. 82, 1821–1827.

  16. 16.

    Barna, M., Komatsu, T., Bi, Z., and Reiss, C. S. (1996), J. Neuroimmunol. 67, 31–39.

  17. 17.

    Gunderson, E. K., Garland, C., and Hourani, L. L. (2001), Mil. Med. 166, 544–549.

  18. 18.

    Remoue, F., To Van, D., Schacht, A. M., Picquet, M., Garraud, O., Vercruysse, J., et al. (2001), Clin. Exp. Immunol. 124, 62–68.

  19. 19.

    Ortmeyer, L. E. (1979), women Health 4, 121–133.

  20. 20.

    Kaya, Z., Afanasyeva, M., Wang, Y., Dohmen, K. M., Schlichting, J., Tretter, T., et al. (2001), Nat. Immunol. 2, 739–745.

  21. 21.

    Shi, F., Ljunggren, H. G., and Sarvetnick, N. (2001) Trends Immunol. 22, 97–101.

  22. 22.

    Sarvetnick, N. and Fox, H. S. (1990), Mol. Biol. Med. 7, 323–331.

  23. 23.

    Merrill, J. T., Dinu, A. R., and Lahita, R. G. (1996), Medscape Womens Health 1, 5.

  24. 24.

    McMurray, R. W. (2001), Int. Immunopharmacol. 1, 995–1008.

  25. 25.

    Rider, V. and Abdou, N. I. (2001), Int. Immunopharmacol. 1, 1009–1024.

  26. 26.

    Tornwall, J., Carey, A. B., Fox, R. I., and Fox, H. S. (1999), J. Gend. Specif. Med. 2, 33–40.

  27. 27.

    Caligiuri, G., Nicoletti, A., Zhou, X., Tornberg, I., and Hansson, G. K. (1999), Atherosclerosis 145 301–308.

  28. 28.

    Ahmed, S. A., Hissong, B. D., Verthelyi, D., Donner, K., Becker, K., and Karpuzoglu-Sahin, E. (1999), Environ. Health Perspect. 107, 681–686.

  29. 29.

    Holmdahl, R., Jansson, L., and Andersson, M. (1986), Arthritis Rheum. 29, 1501–1599.

  30. 30.

    Martin, J. T. (2000), Eur. J. Pharmacol. 405, 251–261.

  31. 31.

    Offner, H., Adlard, K., Zamora, A., and Vandenbark, A. A. (2000), J. Clin. Invest. 105, 1465–1472.

  32. 32.

    Rider, V., Foster, R. T., Evans, M., Suenaga, R., and Abdou, N. I. (1998), Clin. Immunol. Immunopathol. 89, 171–180.

  33. 33.

    Bebo, B. F., Jr., Schuster, J. C., Vandenbark, A. A., and Offner, H. (1999), J. Immunol. 162, 35–40.

  34. 34.

    Da Silva, J. A. (1995), Ann. Rheum. Dis. 54, 6–16.

  35. 35.

    Da Silva, J. A. (1999), Ann. NY Acad. Sci. 876, 102–117; discussion 117–118.

  36. 36.

    Gaillard, R. C. and Spinedi, E. (1998), Domest. Anim. Endocrinol. 15, 345–352.

  37. 37.

    Magiakou, M. A., Mastorakos, G., Webster, E., and Chrousos, G. P. (1997), Ann. NY Acad. Sci. 816, 42–56.

  38. 38.

    Olsen, N. J. and Kovacs, W. J. (1996), Endocr. Rev. 17, 369–384.

  39. 39.

    Schuurs, A. H. and Verheul, H. A. (1990), J. Steroid Biochem. 35, 157–172.

  40. 40.

    Slavkin, H. C. (1998), J. Am. Dent. Assoc. 129, 357–361.

  41. 41.

    Fox, H. S. (1995), Ciba Found. Symp. 191, 203–211; discussion 211–217.

  42. 42.

    Lucas, C., Bald, L. N., Martin, M. C., Jaffe, R. B., Drolet, D. W., Mora-Worms, M., et al. (1989), J. Endocrinol. 120, 449–457.

  43. 43.

    Medawar, P. B. (1954), Symp. Soc. Exp. Biol., vol. 7.

  44. 44.

    Mellor, A. L. and Munn, D. H. (2001), Semin. Immunol. 13, 213–218.

  45. 45.

    Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., et al. (1998), Science 281, 1191–1193.

  46. 46.

    Matzinger, P. (1994), Annu. Rev. Immunol. 12, 991–1045.

  47. 47.

    Bonney, E. A. and Matzinger, P. (1998), Nat. Med. 4, 1128–1129.

  48. 48.

    Clark, D. A. and Croitoru, K. (2001), Am. J. Reprod. Immunol. 45, 257–265.

  49. 49.

    Oakley, C. M., Gravanis, M. B., and Ansari, A. (1993), in Cardiovascular Disorders, Gravanis, M. B., ed. Mosby Yearbook Inc., St. Louis, pp. 210–253.

  50. 50.

    Herskowitz, A. and Baughman, K. (1993), in Cardiovascular Disorders, Gravanis, M. B., ed., Mosby Yearbook Inc., St. Louis, pp. 178–209.

  51. 51.

    Redondo, M. J., Rewers, M., Yu, L., Garg, S., Pilcher, C. C., Elliott, R. B., and Eisenbarth, G. S. (1999), BMJ 318, 698–702.

  52. 52.

    Tomer, Y. and Davies, T. F. (1997), Baillieres Clin. Endocrinol. Metab. 11, 431–450.

  53. 53.

    Fett, J. D., Sundstrom, J. B., King, M. E., and Ansari, A. A. (2002) Int. J. Cardiol, in press.

  54. 54.

    Lo, Y. M., Lo, Y. M., Lo, E. S., Watson, N., Noakes, L., Sargent, I. L., et al. (1996), Blood 88, 4390–4395.

  55. 55.

    Prigoshin, N., Tambutti, M. L., Redal, M. A., Gorgorza, S., Lancuba, S. M., Nicholson, R., and Testa, R. (1999), J. Reprod. Immunol. 44, 41–54.

  56. 56.

    Starzl, T. E., Demetris, A. J., Murase, N., Ildstad, S., Ricordi, C., and Trucco, M. (1992), Lancet 339, 1579–1582.

  57. 57.

    Waldmann, H. (1999), Nat. Med. 5, 1245–1248.

  58. 58.

    Bianchi, D. W. (1998), J. Perinat. Med. 26, 175–185.

  59. 59.

    Bianchi, D. W., Zickwolf, G. K., Weil, G. J., Sylvester, S., and DeMaria, M. A. (1996), Proc. Natl. Acad. Sci. USA 93, 705–708.

  60. 60.

    Aractingi, S., Berkane, N., Bertheau, P., Le Goue, C. Dausset, J., Uzan, S., and Carosella, E. D. Lancet 352, 1898–1901.

  61. 61.

    Nelson, J. L., Furst, D. E., Maloney, S., Gooley, T., Evans, P. C., Smith, A., et al. (1998), Lancet 351, 559–562.

  62. 62.

    Tanaka, A., Lindor, K., Gish, R., Batts, K., Shiratori, Y., Omata, M., et al. (1999), Hepatology 30, 833–838.

  63. 63.

    Symmons, D. P., Bankhead, C. R., Harrison, B. J., Brennan, P., Barrett, E. M., Scott, D. G., and Silman, A. J. (1997), Arthritis Rheum. 40, 1955–1961.

  64. 64.

    Peng, T., Li, Y., Yang, Y., Niu, C., Morgan-Capner, P., Archard, L. C., and Zhang, H. (2000), J. Clin. Microbiol. 38, 3538–3543.

  65. 65.

    Fett, J. D., Ansari, A. A., Sundstrom, J. B., and Combs, G. F., Jr. (2002) Int. J. Cardiol., submitted.

  66. 66.

    Ansari, A. A., Neckelmann, N., Villinger, F., Leung, P., Danner, D. J., Brar, S. S., et al. (1994), J. Immunol. 153, 4754–4765.

Download references

Author information

Correspondence to Aftab A. Ansari.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ansari, A.A., Fett, J.D., Carraway, R.E. et al. Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clinic Rev Allerg Immunol 23, 301 (2002). https://doi.org/10.1385/CRIAI:23:3:301

Download citation

Index Entries

  • Peripartum cardiomyopathy
  • autoimmune diseases
  • pregnancy
  • immune abnormalities
  • microchimerism